Ubs Group Ag Maia Biotechnology, Inc. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 16,685 shares of MAIA stock, worth $37,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,685Holding current value
$37,708% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding MAIA
# of Institutions
18Shares Held
1.47MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA566KShares$1.28 Million0.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN377KShares$851,3730.56% of portfolio
-
Geode Capital Management, LLC Boston, MA193KShares$435,1920.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$177,4570.0% of portfolio
-
Centric Wealth Management68.2KShares$154,1740.05% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $24.7M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...